We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

195 hedge funds and large institutions have $2.62B invested in NEVRO CORP. in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 91 increasing their positions, 60 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 60

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

7% less funds holding

Funds holding: 209195 (-14)

11% less capital invested

Capital invested by funds: $2.95B → $2.62B (-$332M)

26% less call options, than puts

Call options by funds: $21.1M | Put options by funds: $28.4M

41% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 32

Holders
195
Holders Change
-14
Holders Change %
-6.7%
% of All Funds
3.08%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
19
Increased
91
Reduced
60
Closed
32
Calls
$21.1M
Puts
$28.4M
Net Calls
-$7.36M
Net Calls Change
+$1.76M
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$28.6M -$1.33M -18,491 -4%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$27.7M +$9.65M +133,892 +54%
Artisan Partners
28
Artisan Partners
Wisconsin
$26.7M -$172K -2,391 -0.6%
Deutsche Bank
29
Deutsche Bank
Germany
$26.7M +$23.2M +322,435 +692%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$25.1M -$854K -11,840 -3%
Northern Trust
31
Northern Trust
Illinois
$23.8M -$1.03M -14,283 -4%
PAMS
32
Pictet Asset Management (Switzerland)
Switzerland
$21.6M +$4.89M +67,826 +29%
WP
33
Woodline Partners
California
$20M +$12.8M +177,876 +180%
Federated Hermes
34
Federated Hermes
Pennsylvania
$19.8M +$17.2M +238,677 +673%
Charles Schwab
35
Charles Schwab
California
$18.3M +$522K +7,237 +3%
Capital World Investors
36
Capital World Investors
California
$18.3M
Massachusetts Financial Services
37
Massachusetts Financial Services
Massachusetts
$17.6M -$5.43M -75,306 -24%
Two Sigma Advisers
38
Two Sigma Advisers
New York
$17.4M +$7.51M +104,100 +77%
BG
39
Bellevue Group
Switzerland
$17.2M
Voloridge Investment Management
40
Voloridge Investment Management
Florida
$16.3M +$2.66M +36,947 +20%
Bank of America
41
Bank of America
North Carolina
$12.2M +$3.31M +45,933 +37%
BNP Paribas Asset Management
42
BNP Paribas Asset Management
France
$11.9M -$1M -13,938 -8%
LCM
43
Laurion Capital Management
New York
$11.5M +$11.5M +158,917 New
Jennison Associates
44
Jennison Associates
New York
$10.7M -$11.9M -165,001 -53%
Lazard Asset Management
45
Lazard Asset Management
New York
$10.6M +$10.5M +145,969 +33,633%
JG
46
Jefferies Group
New York
$10M +$5.08M +70,481 +103%
N
47
Nuveen
North Carolina
$9.51M +$2.69M +37,354 +36%
CCM
48
Cinctive Capital Management
New York
$8.38M +$4.93M +68,417 +144%
Canada Pension Plan Investment Board
49
Canada Pension Plan Investment Board
Ontario, Canada
$7.23M -$3.05M -42,300 -30%
Jacobs Levy Equity Management
50
Jacobs Levy Equity Management
New Jersey
$7.07M -$2.44M -33,878 -26%

NVRO Hedge Fund Activity: Q1 2022 in Review

195 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q1 2022, worth a combined $2.62B — down 11% from $2.95B a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of NVRO and 19 opened new positions — a net loss of 13 holders — while 60 trimmed existing stakes and 91 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $55.1M. The largest seller was Jackson Square Partners, exiting entirely with an estimated $198M sold.

  • 195 institutional investors held NEVRO CORP. (NVRO) as of Q1 2022, down from 209 in Q4 2021.
  • Funds reported $2.62B of NEVRO CORP. stock for Q1 2022, down 11% quarter-over-quarter.
  • 19 funds opened new NEVRO CORP. positions in Q1 2022 and 32 closed out, a net change of -13 holders.
  • The largest NEVRO CORP. buyer in Q1 2022 was T. Rowe Price Associates, an estimated $55.1M added.
  • The largest NEVRO CORP. seller in Q1 2022 was Jackson Square Partners, an estimated $198M sold.

Based on aggregated 13F filings for Q1 2022.